Table of Contents Author Guidelines Submit a Manuscript
Journal of Thyroid Research
Volume 2012, Article ID 182176, 11 pages
http://dx.doi.org/10.1155/2012/182176
Clinical Study

Changes of TSH-Stimulation Blocking Antibody (TSBAb) and Thyroid Stimulating Antibody (TSAb) Over 10 Years in 34 TSBAb-Positive Patients with Hypothyroidism and in 98 TSAb-Positive Graves’ Patients with Hyperthyroidism: Reevaluation of TSBAb and TSAb in TSH-Receptor-Antibody (TRAb)-Positive Patients

Department of Endocrinology and Metabolism, Aizawa Hospital, 2-5-1 Honjo, Mtasumoto 390-8521, Japan

Received 31 August 2011; Revised 22 January 2012; Accepted 24 January 2012

Academic Editor: Terry F. Davies

Copyright © 2012 Nobuyuki Takasu and Mina Matsushita. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Takasu, C. Oshiro, H. Akamine et al., “Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects,” Journal of Endocrinological Investigation, vol. 20, no. 8, pp. 452–461, 1997. View at Google Scholar · View at Scopus
  2. N. Takasu, K. Kamijo, Y. Sato et al., “Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves' disease,” Clinical and Experimental Pharmacology and Physiology, vol. 31, no. 5-6, pp. 314–319, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Takasu, T. Yamada, M. Takasu et al., “Disappearance of thyrotropin-blocking antibodies and spontaneous recovery from hypothyroidism in autoimmune thyroiditis,” The New England Journal of Medicine, vol. 326, no. 8, pp. 513–518, 1992. View at Google Scholar · View at Scopus
  4. K. Endo, K. Kasagi, J. Konishi et al., “Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis,” Journal of Clinical Endocrinology and Metabolism, vol. 46, no. 5, pp. 734–739, 1978. View at Google Scholar · View at Scopus
  5. B. R. Smith and R. Hall, “Measurement of thyrotropin receptor antibodies,” Methods in Enzymology, vol. 74, pp. 405–420, 1981. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Kasagi, J. Konishi, and Y. Iida, “A new in vitro assay for human thyroid stimulator using cultured thyroid cells: effect of sodium chloride on adenosine 3',5'-monophosphate increase,” Journal of Clinical Endocrinology and Metabolism, vol. 54, no. 1, pp. 108–114, 1982. View at Google Scholar · View at Scopus
  7. T. F. Davies, M. Platzer, A. Schwartz et al., “Functionality of thyroid-stimulating antibodies assessed by cryopreserved human thyroid cell bioassay,” Journal of Clinical Endocrinology and Metabolism, vol. 57, no. 5, pp. 1021–1027, 1983. View at Google Scholar · View at Scopus
  8. B. Rapoport, F. S. Greenspan, S. Filetti et al., “Clinical experience with a human thyroid cell bioassay for thyroid-stimulating immunoglobulin,” Journal of Clinical Endocrinology and Metabolism, vol. 58, no. 2, pp. 332–338, 1984. View at Google Scholar · View at Scopus
  9. M. Ludgate, J. Perret, M. Parmentier et al., “Use of the recombinant human thyrotropin receptor (TSH-R) expressed in mammalian cell lines to assay TSH-R autoantibodies,” Molecular and Cellular Endocrinology, vol. 73, no. 1, pp. R13–R18, 1990. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Takasu, T. Mori, Y. Koizumi et al., “Transient neonatal hypothyroidism due to maternal immunoglobulins that inhibit thyrotropin-binding and post-receptor processes,” Journal of Clinical Endocrinology and Metabolism, vol. 59, no. 1, pp. 142–146, 1984. View at Google Scholar · View at Scopus
  11. N. Takasu, T. Yamada, M. Katakura et al., “Evidence for thyrotropin (TSH)-blocking activity in goitrous Hashimoto's thyroiditis with assays measuring inhibition of TSH receptor binding and TSH-stimulated thyroid adenosine 3',5'-monophosphate responses/cell growth by immunoglobulins,” Journal of Clinical Endocrinology and Metabolism, vol. 64, no. 2, pp. 239–245, 1987. View at Google Scholar · View at Scopus
  12. N. Takasu, T. Yamada, A. Sato et al., “Graves' disease following hypothyroidism due to Hashimoto's disease: studies of eight cases,” Clinical Endocrinology, vol. 33, no. 6, pp. 687–698, 1990. View at Google Scholar · View at Scopus
  13. N. Takasu, K. Yamashiro, Y. Ochi et al., “TSBAb (TSH-stimulation blocking antibody) and TSAb (Thyroid stimulating antibody) in TSBAb-positive patients with hypothyroidism and graves' patients with hyperthyroidism,” Hormone and Metabolic Research, vol. 33, no. 4, pp. 232–237, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Takasu, K. Yamashiro, I. Komiya et al., “Remission of graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment,” Thyroid, vol. 10, no. 10, pp. 891–896, 2000. View at Google Scholar · View at Scopus
  15. T. Kouki, T. Inui, K. Yamashiro et al., “Demonstration of fragments with thyroid stimulating activity from Thyroid stimulation blocking antibodies-IgG molecules by papain digestion,” Clinical Endocrinology, vol. 47, no. 6, pp. 693–698, 1997. View at Google Scholar · View at Scopus
  16. J. Konishi, Y. Iida, K. Endo et al., “Inhibition of thyrotropin-induced adenosine 3'5'-monophosphate increase by immunoglobulins from patients with primary myxedema,” Journal of Clinical Endocrinology and Metabolism, vol. 57, no. 3, pp. 544–549, 1983. View at Google Scholar · View at Scopus
  17. H. Inomata, N. Sasaki, and K. Tamaru, “Relationship between potency of blocking type thyrotropin-binding inhibitor immunoglobulin in three women with primary myxedema and thyroid function of their neonates,” Endocrinologia Japonica, vol. 33, no. 3, pp. 353–359, 1986. View at Google Scholar · View at Scopus
  18. N. Yokoyama, M. Izumi, S. Katamine et al., “Heterogeneity of Graves immunoglobulin G: comparison of thyrotropin receptor antibodies in serum and in culture supernatants of lymphocytes transformed by Epstein-Barr virus infection,” Journal of Clinical Endocrinology and Metabolism, vol. 64, no. 2, pp. 215–218, 1987. View at Google Scholar · View at Scopus
  19. I. Matsui, S. Sakata, T. Ogawa et al., “Biological activities of rat antisera raised against synthetic peptides of human thyrotropin receptor,” Endocrine Journal, vol. 40, no. 5, pp. 607–612, 1993. View at Google Scholar · View at Scopus
  20. Y. Hidaka, V. Guimaraes, M. Soliman et al., “Production of thyroid-stimulating antibodies in mice by immunization with T-cell epitopes of human thyrotropin receptor,” Endocrinology, vol. 136, no. 4, pp. 1642–1647, 1995. View at Google Scholar · View at Scopus
  21. E. Macchia, R. Concetti, G. Carone et al., “Demonstration of blocking immunoglobulins G, having a heterogeneous behaviour, in sera of patients with Graves' disease: possible coexistence of different autoantibodies directed to the TSH receptor,” Clinical Endocrinology, vol. 28, no. 2, pp. 147–156, 1988. View at Google Scholar · View at Scopus
  22. A. Miyauchi, N. Amino, H. Tamaki et al., “Coexistence of thyroid-stimulating and thyroid-blocking antibodies in a patient with Graves' disease who had transient hypothyroidism,” The American Journal of Medicine, vol. 85, no. 3, pp. 418–420, 1988. View at Google Scholar · View at Scopus
  23. H. Tamai, K. Kasagi, Y. Takaichi et al., “Development of spontaneous hypothyroidism in patients with Graves' disease treated with antithyroidal drugs: clinical, immunological, and histological findings in 26 patients,” Journal of Clinical Endocrinology and Metabolism, vol. 69, no. 1, pp. 49–53, 1989. View at Google Scholar · View at Scopus
  24. K. Kasagi, A. Hidaka, K. Endo et al., “Fluctuating thyroid function depending on the balance between stimulating and blocking types of TSH receptor antibodies: a case report,” Thyroid, vol. 3, no. 4, pp. 315–318, 1993. View at Google Scholar · View at Scopus
  25. K. Takeda, J. Takamatsu, K. Kasagi et al., “Development of hyperthyroidism following primary hypothyroidism: a case report with changes in thyroid-related antibodies,” Clinical Endocrinology, vol. 28, no. 4, pp. 341–344, 1988. View at Google Scholar · View at Scopus
  26. V. P. Michelangeli, C. Poon, D. J. Topliss et al., “Specific effects of radioiodine treatment on TSAb and TBAb levels in patients with Graves' disease,” Thyroid, vol. 5, no. 3, pp. 171–176, 1995. View at Google Scholar · View at Scopus